株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

インフルエンザ診断の世界市場:検査の種類別(従来型診断 (RIDT、直接蛍光抗体、ウイルス培養、血清)、分子診断 (RT-PCR、INAAT (NASBA、LAMP)))・エンドユーザー別 (病院、検査室、教育機関など) の将来予測 (2027年まで)

Influenza Diagnostics Market by Test Type {[Traditional (RIDT, Direct Fluorescent Antibody, Viral Culture, Serology), Molecular [RT-PCR, INAAT (NASBA, LAMP)]}, End User (Hospitals, Laboratories, Academics, & Others)-Global Forecast to 2027

発行 Meticulous Market Research Pvt. Ltd. 商品コード 942393
出版日 ページ情報 英文 169 Pages
即納可能
価格
本日の銀行送金レート: 1USD=108.31円で換算しております。
インフルエンザ診断の世界市場:検査の種類別(従来型診断 (RIDT、直接蛍光抗体、ウイルス培養、血清)、分子診断 (RT-PCR、INAAT (NASBA、LAMP)))・エンドユーザー別 (病院、検査室、教育機関など) の将来予測 (2027年まで) Influenza Diagnostics Market by Test Type {[Traditional (RIDT, Direct Fluorescent Antibody, Viral Culture, Serology), Molecular [RT-PCR, INAAT (NASBA, LAMP)]}, End User (Hospitals, Laboratories, Academics, & Others)-Global Forecast to 2027
出版日: 2020年06月15日 ページ情報: 英文 169 Pages
概要

世界のインフルエンザ診断市場は、2019~2027年に7.9%のCAGRで成長し、2027年までに11億7000万米ドルの規模に達する、と予想されています。市場成長の主な要因として、主にインフルエンザの有病率の増加、早期発見に対する意識の高まり、CLIA免除POC分子インフルエンザテストの開発、集中型検査室から分散型ポイントへの焦点の移行などが挙げられます。また、新興国市場 (インド、ブラジル、中国など) が世界中のベンダーに大きな成長機会を提供しています。

当レポートでは、世界のインフルエンザ診断市場について分析し、市場の基本構造や主な促進・抑制要因、全体的な市場動向見通し (過去2年間・今後7年間分)、検査の種類別・エンドユーザー別・地域別の詳細動向、近年の市場競争・資本取引の動き、主要企業のプロファイルなどを調査しております。

第1章 イントロダクション

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 市場の考察

  • イントロダクション
  • 市場促進要因
    • インフルエンザの世界的流行の増加
    • インフルエンザの早期診断に対する認識の高まり
    • CLIA免除POC分子インフルエンザ検査の開発
    • 検査サービス:試験室集中型からPoC方式への移行
  • 市場抑制要因
    • 中~高度の複雑性テストの技術要件と規制プロセス
  • 市場機会
    • ゲノミクスとプロテオミクスの進歩
    • 新興国の成長機会
  • 課題
    • 不利で不十分な償還シナリオ
  • 新型コロナウイルス感染症 (Covid-19) の影響

第5章 世界のインフルエンザ診断市場:検査の種類別

  • イントロダクション
  • 従来型の診断検査
    • インフルエンザの迅速診断テスト(RIDT)
    • 直接蛍光抗体(DFA)検査
    • ウイルス培養
    • 血清アッセイ
  • 分子診断検査
    • 逆転写ポリメラーゼ連鎖反応(RT-PCR)
    • 等温核酸増幅試験(INAAT)
    • その他の分子診断検査

第6章 世界のインフルエンザ診断市場:エンドユーザー別

  • イントロダクション
  • 病院・臨床検査室
  • 診断/参考検査室
  • 教育・研究機関
  • その他のエンドユーザー

第7章 世界のインフルエンザ診断市場:地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • 他の欧州諸国
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • 他のアジア太平洋諸国
  • ラテンアメリカ
  • 中東・アフリカ

第8章 競争環境

  • イントロダクション
  • 主な成長戦略
  • 企業間の比較分析
  • 市場シェア分析(2019年)
    • F. Hoffmann-La Roche Ltd
    • Quidel Corporation
    • Thermo Fisher Scientific, Inc.
    • Abbott Laboratories
    • その他の企業

第9章 企業プロファイル(事業概要、主な財務指標、製品ポートフォリオ、戦略展開状況)

  • Thermo Fisher Scientific, Inc.
  • Abbott Laboratories
  • Danaher Corporation
  • Bio-Rad Laboratories, Inc.
  • BioMerieux S.A.
  • F. Hoffmann-La Roche Ltd.
  • Becton, Dickinson and Company
  • Meridian Bioscience, Inc.
  • Quidel Corporation
  • Hologic, Inc.
  • Siemens Healthineers AG (Siemens AGの子会社)
  • Luminex Corporation
  • GenMark Diagnostics, Inc.
  • Altona Diagnostics GmbH
  • SA Scientific, Ltd.
  • Sekisui Diagnostics, LLC
  • CorisBioconcept SPRL
  • ELITech Group
  • Mast Group, Ltd.
  • Response Biomedical Corporation
  • Germaine Laboratories, Inc.

第10章 付録

図表

List of Tables

  • Table 1 Global Influenza Diagnostics Market Drivers: Impact Analysis (2020-2027)
  • Table 2 Europe: Percentage of Specimens Positive for Influenza, 2015-2020
  • Table 3 Global Influenza Diagnostics Market Restraint: Impact Analysis (2020-2027)
  • Table 4 Some Clinical Applications of Influenza Genomics and Proteomics
  • Table 5 COVID 19 Confirmed Cases and Deaths across the World (27th May 2020)
  • Table 6 Influenza Diagnostics Market Size, by Test Type, 2018-2027 ($ Million)
  • Table 7 Traditional Influenza Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 8 Traditional Influenza Diagnostic Tests Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 9 Advantages & Disadvantages of RIDT
  • Table 10 RIDTs Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 11 Direct Fluorescent Antibody Tests Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 12 Viral Culture Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 13 Serological Assays Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 14 Molecular Influenza Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 15 Molecular Influenza Diagnostic Tests Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 16 Comparison of RT-PCR with Traditional Diagnostic Tests
  • Table 17 RT-PCR Tests Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 18 INAAT Based Influenza Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 19 INAAT Based Influenza Diagnostics Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 20 Loop-Mediated Isothermal Amplification (Lamp) Assays Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 21 Transcription Mediated Isothermal Based Amplification Assays Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 22 Nucleic Acid Sequence-Based Amplification Tests Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 23 Other INAAT Assays Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 24 Other Molecular Influenza Diagnostic Tests Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 25 Influenza Diagnostics Market Size, by End User, 2018-2027 ($ Million)
  • Table 26 Influenza Diagnostics Market Size for Hospital & Clinical Laboratories, by Country/Region, 2018-2027 ($ Million)
  • Table 27 Influenza Diagnostics Market Size for Diagnostic Reference Laboratories, by Country/Region, 2018-2027 ($Million)
  • Table 28 Influenza Diagnostics Market Size for Academics/Research Institutes, by Country/Region, 2018-2027 ($Million)
  • Table 29 Influenza Diagnostics Market Size for Other End Users, by Country/Region, 2018-2027 ($Million)
  • Table 30 Influenza Diagnostics Market Size, by Country/Region, 2018-2027 ($Million)
  • Table 31 North America: Influenza Diagnostics Market Size, by Country, 2018-2027 ($Million)
  • Table 32 North America: Influenza Diagnostics Market Size, by Test Type, 2018-2027 ($Million)
  • Table 33 North America: Traditional Influenza Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 34 North America: Molecular Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 35 North America: Isothermal Nucleic Acid Amplification Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 36 North America: Influenza Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 37 U.S.: Influenza Diagnostics Market Size, by Test Type, 2018-2027 ($Million)
  • Table 38 U.S.: Traditional Influenza Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 39 U.S.: Molecular Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 40 U.S.: Isothermal Nucleic Acid Amplification Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 41 U.S.: Influenza Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 42 Canada: Influenza Diagnostics Market Size, by Test Type, 2018-2027 ($Million)
  • Table 43 Canada: Traditional Influenza Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 44 Canada: Molecular Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 45 Canada: Isothermal Nucleic Acid Amplification Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 46 Canada: Influenza Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 47 Europe: Influenza Diagnostics Market Size, by Country, 2018-2027 ($Million)
  • Table 48 Europe: Influenza Diagnostics Market Size, by Test Type, 2018-2027 ($Million)
  • Table 49 Europe: Traditional Influenza Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 50 Europe: Molecular Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 51 Europe: Isothermal Nucleic Acid Amplification Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 52 Europe: Influenza Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 53 Germany: Influenza Diagnostics Market Size, by Test Type, 2018-2027 ($Million)
  • Table 54 Germany: Traditional Influenza Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 55 Germany: Molecular Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 56 Germany: Isothermal Nucleic Acid Amplification Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 57 Germany: Influenza Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 58 France: Influenza Diagnostics Market Size, by Test Type, 2018-2027 ($Million)
  • Table 59 France: Traditional Influenza Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 60 France: Molecular Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 61 France: Isothermal Nucleic Acid Amplification Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 62 France: Influenza Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 63 Number of Acute Respiratory Illness Outbreaks in the U.K. by Institution Type: 2015-2019
  • Table 64 U.K.: Influenza Diagnostics Market Size, by Test Type, 2018-2027 ($Million)
  • Table 65 U.K.: Traditional Influenza Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 66 U.K.: Molecular Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 67 U.K.: Isothermal Nucleic Acid Amplification Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 68 U.K.: Influenza Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 69 Italy: Influenza Diagnostics Market Size, by Test Type, 2018-2027 ($Million)
  • Table 70 Italy: Traditional Influenza Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 71 Italy: Molecular Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 72 Italy: Isothermal Nucleic Acid Amplification Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 73 Italy: Influenza Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 74 Spain: Influenza Diagnostics Market Size, by Test Type, 2018-2027 ($Million)
  • Table 75 Spain: Traditional Influenza Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 76 Spain: Molecular Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 77 Spain: Isothermal Nucleic Acid Amplification Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 78 Spain: Influenza Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 79 Rest of Europe: Influenza Diagnostics Market Size, by Test Type, 2018-2027 ($Million)
  • Table 80 Rest of Europe: Traditional Influenza Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 81 Rest of Europe: Molecular Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 82 Rest of Europe: Isothermal Nucleic Acid Amplification Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 83 Rest of Europe: Influenza Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 84 Asia-Pacific: Influenza Diagnostics Market Size, by Country, 2018-2027 ($Million)
  • Table 85 Asia-Pacific: Influenza Diagnostics Market Size, by Test Type, 2018-2027 ($Million)
  • Table 87 Asia-Pacific: Molecular Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 88 Asia-Pacific: Isothermal Nucleic Acid Amplification Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 89 Asia-Pacific: Influenza Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 90 China: Influenza Diagnostics Market Size, by Test Type, 2018-2027 ($Million)
  • Table 91 China: Traditional Influenza Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 92 China: Molecular Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 93 China: Isothermal Nucleic Acid Amplification Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 94 China: Influenza Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 95 Japan: Influenza Diagnostics Market Size, by Test Type, 2018-2027 ($Million)
  • Table 96 Japan: Traditional Influenza Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 97 Japan: Molecular Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 98 Japan: Isothermal Nucleic Acid Amplification Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 99 Japan: Influenza Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 100 India: Influenza Diagnostics Market Size, by Test Type, 2018-2027 ($Million)
  • Table 101 India: Traditional Influenza Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 102 India: Molecular Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 103 India: Isothermal Nucleic Acid Amplification Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 104 India: Influenza Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 105 Rest of Asia-Pacific: Influenza Diagnostics Market Size, by Test Type, 2018-2027 ($Million)
  • Table 106 Rest of Asia-Pacific: Traditional Influenza Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 107 Rest of Asia-Pacific: Molecular Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 108 Rest of Asia-Pacific: Isothermal Nucleic Acid Amplification Tests Market Size, 2018-2027 ($Million)
  • Table 109 Rest of Asia-Pacific: Influenza Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 110 Latin America: Influenza Diagnostics Market Size, by Test Type, 2018-2027 ($Million)
  • Table 111 Latin America: Traditional Influenza Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 112 Latin America: Molecular Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 113 Latin America: Isothermal Nucleic Acid Amplification Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 114 Latin America: Influenza Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 115 Middle East & Africa: Influenza Diagnostics Market Size, by Test Type, 2018-2027 ($Million)
  • Table 116 Middle East & Africa: Traditional Influenza Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 117 Middle East & Africa: Molecular Diagnostic Tests Market Size, by Type, 2018-2027 ($Million)
  • Table 118 Middle East & Africa: Isothermal Nucleic Acid Amplification Tests Market Size, 2018-2027 ($Million)
  • Table 119 Middle East & Africa: Influenza Diagnostics Market Size, by End User, 2018-2027 ($Million)
  • Table 120 Recent Developments, by Company, 2017-2020

List of Figures

  • Figure 1 Key Stakeholders
  • Figure 2 Research Process
  • Figure 3 Key Secondary Sources
  • Figure 4 Primary Research Techniques
  • Figure 5 Key Executives Interviewed
  • Figure 6 Breakdown of Primary Interviews (Supply-Side & Demand-Side)
  • Figure 7 Market Size Estimation
  • Figure 8 Global Influenza Diagnostics Market, by Test Type, 2020 Vs 2027 ($Million)
  • Figure 9 Global Influenza Diagnostics Market Overview, by End User, 2020-2027 ($Million)
  • Figure 10 Regional Snapshot: Influenza Diagnostics Market
  • Figure 11 Market Dynamics
  • Figure 12 Global Influenza Transmission Zone
  • Figure 13 U.S. Influenza Burden (2010-2018)
  • Figure 14 Global Influenza Diagnostics Market Size, by Test Type, 2020-2027 ($Million)
  • Figure 15 Global Influenza Diagnostics Market Size, by End User, 2020-2027 ($Million)
  • Figure 16 Global Influenza Diagnostics Market Size, by Geography, 2020-2027 ($Million)
  • Figure 17 North America: Influenza Diagnostics Market Snapshot
  • Figure 18 Population Aged 65 or above (As % of total Population) in the U.S.:2012-2018
  • Figure 19 Europe: Influenza Diagnostics Market Snapshot
  • Figure 20 Healthcare Spending Per Capita in France: 2015-2018
  • Figure 21 Proportion of Population Aged 65 or Above (As % of total Population)
  • Figure 22 Influenza Cases in Spain per 100,000 Inhabitants: 2015-2019
  • Figure 23 Per Capita Health Spending by Country, 2018 ($)
  • Figure 24 Asia-Pacific: Influenza Diagnostics Snapshot
  • Figure 25 Number of Geriatric Population (Aged 65 & Above) In China: 2010-2050(In Millions)
  • Figure 26 Number of Swine Flu Cases in India: 2012-2018
  • Figure 27 Population Aged 60 & Above In Latin America: 2000-2050 (In Millions)
  • Figure 28 Key Growth Strategies Adopted by Leading Players, 2017-2020
  • Figure 29 Influenza Diagnostics Market: Competitive Benchmarking
  • Figure 30 Global Influenza Diagnostics Market Share Analysis, by Key Players, 2019 (%)
  • Figure 31 thermo Fisher Scientific, Inc.: Financial Overview (2019)
  • Figure 32 Abbott Laboratories: Financial Overview (2019)
  • Figure 33 Danaher Corporation: Financial Overview (2019)
  • Figure 34 Bio-Rad Laboratories, Inc.: Financial Overview (2019)
  • Figure 35 BioMerieux S.A.: Financial Overview (2018)
  • Figure 36 F. Hoffmann-La Roche Ltd: Financial Overview (2019)
  • Figure 37 Becton, Dickinson and Company: Financial Overview (2019)
  • Figure 38 Meridian Bioscience, Inc.: Financial Overview (2019)
  • Figure 39 Quidel Corporation: Financial Overview (2019)
  • Figure 40 Hologic, Inc.: Financial Overview (2019)
  • Figure 41 Siemens Healthineers Ag: Financial Overview (2019)
  • Figure 42 Luminex Corporation: Financial Overview (2019)
  • Figure 43 GenMark Diagnostics, Inc.: Financial Overview (2019)
目次

Title:
Influenza Diagnostics
by Test Type {[Traditional (RIDT, Direct Fluorescent Antibody, Viral Culture, Serology), Molecular [RT-PCR, INAAT (NASBA, LAMP)]}, End User (Hospitals, Laboratories, Academics, Research Institutes)-Global Forecast to 2027.

The influenza diagnostics market is expected to grow at a CAGR of 7.9% from 2020 to 2027 to reach $1.17 billion by 2027.

The growth in the influenza diagnostics market is mainly attributed to the factors such as increasing prevalence of influenza, growing awareness for early detection using specific diagnostic tests, development of CLIA-waived POC molecular influenza tests, and shifting focus from centralized laboratories to decentralized point-of-care testing. In addition, advances in genomics and proteomics and emerging markets such as India, Brazil, China, and other countries provide significant growth opportunities for vendors present across the globe.

To provide efficient analysis, Meticulous Research® has segmented this market by test type (traditional diagnostic tests, molecular diagnostic tests), end user (hospital & clinical laboratories, diagnostic reference laboratories, academic/research institutes, and others), and geography (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa).

Based on test type, the traditional diagnostic tests segment is estimated to account for the largest share of the overall influenza diagnostics market in 2020. The large share of this segment is primarily attributed to the wide use of rapid influenza diagnostics tests (RIDTs) due to its cost-effectiveness and ability to provide test results in 15- 30 minutes. In addition, the availability of advanced diagnostic immunoassay formats and increasing usage of miniaturized devices in influenza diagnostics are further stimulating the growth of this segment. However, the molecular diagnostic tests segment is expected to grow at the fastest growth rate during the forecast period.

Based on end user, the diagnostic reference laboratories segment is projected to register the fastest CAGR during the forecast period, mainly due to their nature of supporting the diagnosis required in patient care as well as medical research. Moreover, owing to curtailed reimbursements for laboratory testing services, hospitals prefer to outsource their diagnostic testing services to the large commercial laboratories and eliminate associated operational expenses required for maintaining in-house labs, thereby driving the market.

An in-depth analysis of the geographic scenario of the influenza diagnostics market provides detailed qualitative and quantitative insights about the five major geographies (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa) along with the coverage of major countries in each region. North America region is estimated to dominate the global influenza diagnostics market in 2020, followed by Europe, and Asia Pacific. The factors such as increasing incidence of influenza, higher adoption for technologically advanced diagnostic products, and increase in the research and development activities for influenza supported the largest share of the North America region in the influenza diagnostics market.

The key players operating in the global influenza diagnostics market are Thermo Fisher Scientific Inc. (U.S.), Hologic, Inc. (U.S.), Quidel Corporation (U.S.), F. Hoffmann-La Roche AG (Switzerland), Abbott Laboratories, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Danaher Corporation (U.S.), Meridian Bioscience Inc. (U.S.),bioMerieux SA (France), Luminex Corporation (U.S.), Siemens Healthineers AG (Germany), GenMark Diagnostics, Inc. (U.S.), Sekisui Diagnostics, LLC (U.S.), altona Diagnostics GmbH (Germany), SA Scientific, Ltd. (U.S.), and ELITech Group (France), Coris Bioconcept SPRL (Belgium), and Mast Group Ltd.(U.K.), among others.

Scope of the Report:

Market by Test Type

  • Traditional Diagnostic Tests
    • Rapid influenza diagnostic tests (RIDTs
    • Direct Fluorescent Antibody (DFA) Tests
    • Viral Culture
    • Serological Assays
  • Molecular Diagnostic Tests
    • Reverse Transcription Polymerase Chain Reaction (RT-PCR)
    • Isothermal Nucleic Acid Amplification Tests (INAAT)
    • Loop Mediated Isothermal Based Amplification Assays
    • Transcription Mediated Isothermal Based Amplification Assays
    • Transcription Mediated Isothermal Based Amplification Assays
    • Other Isothermal Nucleic Acid Amplification Tests
    • Other Molecular Diagnostic Tests

Market by End User

  • Hospitals & Clinical Laboratories
  • Diagnostic Reference Laboratories
  • Academic/Research Institutes
  • Others

Market by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • China
    • Japan
    • India
    • Rest of APAC (RoAPAC)
  • Latin America
  • Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Market Definition
  • 1.2. Market Ecosystem
  • 1.3. Currency

2. Research Methodology

  • 2.1. Research Process
  • 2.2. Data Collection & Validation
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research
  • 2.3. Market Assessment
    • 2.3.1. Market Size Estimation
      • 2.3.1.1. Bottom-Up Approach
      • 2.3.1.2. Top-Down Approach
      • 2.3.1.3. Growth forecast
    • 2.3.2. Market Share Analysis
  • 2.4. Assumptions for the Study
  • 2.5. Limitations for the Study

3. Executive Summary

4. Market Insights

  • 4.1. Market Overview
  • 4.2. Drivers
    • 4.2.1. Increasing Global Prevalence of Influenza
    • 4.2.2. Growing Awareness of Early Influenza Diagnosis
    • 4.2.3. Development of CLIA-Waived POC Molecular Influenza Tests
    • 4.2.4. Shift in Focus from Centralized Laboratories to Point-of-Care Testing Services
  • 4.3. Restraints
    • 4.3.1. Technical Requirements and Regulatory Process for High or Moderate Complexity Tests
  • 4.4. Opportunities
    • 4.4.1. Advances in Genomics and Proteomics
    • 4.4.2. Growth Opportunities in Emerging Economies
  • 4.5. Challenges
    • 4.5.1. Unfavorable and Inadequate Reimbursement Scenario
  • 4.6. Impact of Covid-19 Pandemic

5. Global Influenza Diagnostics Market, by Test Type

  • 5.1. Introduction
  • 5.2. Traditional Diagnostic Tests
    • 5.2.1. Rapid Influenza Diagnostics Test (RIDT)
    • 5.2.2. Direct Fluorescent Antibody (DFA) Tests
    • 5.2.3. Viral Culture
    • 5.2.4. Serological Assays
  • 5.3. Molecular Diagnostic Tests
    • 5.3.1. Reverse Transcription Polymerase Chain Reaction (RT-PCR)
    • 5.3.2. Isothermal Nucleic Acid Amplification Tests (INAAT)
      • 5.3.2.1. Loop Mediated Isothermal Based Amplification Assays
      • 5.3.2.2. Transcription Mediated Isothermal Based Amplification Assays
      • 5.3.2.3. Nucleic Acid Sequence-Based Amplification Tests
      • 5.3.2.4. Other Isothermal Nucleic Acid Amplification Assays
    • 5.3.3. Other Molecular Diagnostic Tests

6. Global Influenza Diagnostics Market, by End User

  • 6.1. Introduction
  • 6.2. Hospital & Clinical Laboratories
  • 6.3. Diagnostic Reference Laboratories
  • 6.4. Academic/Research Institutes
  • 6.5. Other End Users

7. Global Influenza Diagnostics Market, by Geography

  • 7.1. Introduction
  • 7.2. North America
    • 7.2.1. U.S.
    • 7.2.2. Canada
  • 7.3. Europe
    • 7.3.1. Germany
    • 7.3.2. France
    • 7.3.3. U.K.
    • 7.3.4. Italy
    • 7.3.5. Spain
    • 7.3.6. Rest of Europe
  • 7.4. Asia-Pacific
    • 7.4.1. China
    • 7.4.2. Japan
    • 7.4.3. India
    • 7.4.4. Rest of Asia-Pacific
  • 7.5. Latin America
  • 7.6. Middle East & Africa

8. Competitive Landscape

  • 8.1. Introduction
  • 8.2. Key Growth Strategies
  • 8.3. Competitive Benchmarking
  • 8.4. Market Share Analysis (2019)
    • 8.4.1. F. Hoffmann-La Roche Ltd
    • 8.4.2. Quidel Corporation
    • 8.4.3. Thermo Fisher Scientific, Inc.
    • 8.4.4. Abbott Laboratories
    • 8.4.5. Other Companies

9. Company Profiles (Business Overview, Financial Overview, Product Portfolio, Strategic Developments)

  • 9.1. Thermo Fisher Scientific, Inc.
  • 9.2. Abbott Laboratories
  • 9.3. Danaher Corporation
  • 9.4. Bio-Rad Laboratories, Inc.
  • 9.5. BioMerieux S.A.
  • 9.6. F. Hoffmann-La Roche Ltd.
  • 9.7. Becton, Dickinson and Company
  • 9.8. Meridian Bioscience, Inc.
  • 9.9. Quidel Corporation
  • 9.10. Hologic, Inc.
  • 9.11. Siemens Healthineers AG (Subsidiary of Siemens AG)
  • 9.12. Luminex Corporation
  • 9.13. GenMark Diagnostics, Inc.
  • 9.14. Altona Diagnostics GmbH
  • 9.15. SA Scientific, Ltd.
  • 9.16. Sekisui Diagnostics, LLC
  • 9.17. CorisBioconcept SPRL
  • 9.18. ELITech Group
  • 9.19. Mast Group, Ltd.
  • 9.20. Response Biomedical Corporation
  • 9.21. Germaine Laboratories, Inc.

10. Appendix

  • 10.1. Questionnaire
  • 10.2. Available Customization